18th Jan 2024 Plain language summary: looking at the enfortumab vedotin plus pembrolizumab treatment combination for untreated locally advanced or metastatic urothelial cancer
11th May 2022 A plain language summary from pembrolizumab plus ipilimumab following PD-1 antibody failure in melanoma